Abstract
Asthma pathogenesis seems to be a result of a complex mixture of genetic and environmental influences. There is evidence that Mycoplasma pneumoniae and Chlamydophila pneumoniae (formerly known as Chlamydia pneumoniae) play a role in promoting airway inflammation that could contribute to the onset and clinical course of asthma. Evidence also indicates that when antimicrobial therapy can eradicate or suppress these organisms, it may be possible to alter the course of the disease. Certain macrolide antibiotics have been shown to improve control of asthma symptoms and lung function in patients diagnosed with acute C. pneumoniae or M. pneumoniae infection. Positive polymerase chain reaction studies for C. pneumoniae or M. pneumoniae are needed to select asthma patients for chronic treatment. Macrolide antibiotics may also have independent anti-inflammatory activity that may be useful in the management of asthma and other inflammatory diseases.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as:• Of importance •• Of major importance
Biscardi S, Lorrot M, Marc E, et al.: Mycoplasma pneumoniae and asthma in children. Clin Infect Dis 2004, 38:1341–1346.
Bisgaard H, Hermansen MN, Buchvald F, et al.: Childhood asthma after bacterial colonization of the airway in neonates. N Engl J Med 2007, 357:1487–1495.
Emre U, Sokolovskaya N, Roblin PM, et al.: Detection of anti-Chlamydia pneumoniae IgE in children with reactive airway disease. J Infect Dis 1995, 172:265–267.
Gil JC, Cedillo RL, Mayagoitia BG, et al.: Isolation of Mycoplasma pneumoniae from asthmatic patients. Ann Allergy 1993, 70:23–25.
Kraft M, Cassell GH, Pak J, et al.: Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin. Chest 2002, 121:1782–1788.
Martin RJ, Kraft M, Chu HW, et al.: A link between chronic asthma and chronic infection. J Allergy Clin Immunol 2001, 107:595–601.
Blasi F, Johnston SL: The role of antibiotics in asthma. Int J Antimicrob Agents 2007, 29:485–493.
Johnston SL, Martin RJ: Chlamydophila pneumoniae and Mycoplasma pneumoniae: a role in asthma pathogenesis? Am J Respir Crit Care Med 2005, 172:1078–1089.
•• Sutherland ER, Martin RJ: Asthma and atypical bacterial infection. Chest 2007, 132:1962–1966. This is an excellent review of important research linking M. pneumoniae and C. pneumoniae to persistent asthma pathogeneis and concerning the benefit of treatment with macrolide antibiotics.
Bradding P, Walls AF, Holgate ST: The role of the mast cell in the pathophysiology of asthma. J Allergy Clin Immunol 2006, 117:1277–1284.
Hanania NA: Targeting airway inflammation in asthma: current and future therapies. Chest 2008, 133:989–998.
Bisgaard H, Flores-Nunez A, Goh A, et al.: Study of montelukast for the treatment of respiratory symptoms of post-respiratory syncytial virus bronchiolitis in children. Am J Respir Crit Care Med 2008, 178:854–860.
Jackson DJ, Gangnon RE, Evans MD, et al.: Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am J Respir Crit Care Med 2008, 178:667–672.
Wos M, Sanak M, Soja J, et al.: The presence of rhinovirus in lower airways of patients with bronchial asthma. Am J Respir Crit Care Med 2008, 177:1082–1089.
Caudri D, Wijga A, Scholtens S, et al.: Early daycare is associated with an increase in airway symptoms in early childhood but is no protection against asthma or atopy at 8 years. Am J Respir Crit Care Med 2009, 180:491–498.
Wark PA, Johnston SL, Bucchieri F, et al.: Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med 2005, 201:937–947.
Esposito S, Principi N: Asthma in children: are chlamydia or mycoplasma involved? Paediatr Drugs 2001, 3:159–168.
Berkovich S, Millian SJ, Snyder RD: The association of viral and mycoplasma infections with recurrence of wheezing in the asthmatic child. Ann Allergy 1970, 28:43–49.
Denlinger LC, Shi L, Guadarrama A, et al.: Attenuated P2X7 pore function as a risk factor for virus-induced loss of asthma control. Am J Respir Crit Care Med 2009, 179:265–270.
Baseman JB, Tully JG: Mycoplasmas: sophisticated, reemerging, and burdened by their notoriety. Emerg Infect Dis 1997, 3:21–32.
Andersen P: Pathogenesis of lower respiratory tract infections due to Chlamydia, Mycoplasma, Legionella and viruses. Thorax 1998, 53:302–307.
Kraft M, Cassell GH, Henson JE, et al.: Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma. Am J Respir Crit Care Med 1998, 158:998–1001.
Chu HW, Honour JM, Rawlinson CA, et al.: Effects of respiratory Mycoplasma pneumoniae infection on allergen-induced bronchial hyperresponsiveness and lung inflammation in mice. Infect Immun 2003, 71:1520–1526.
Chu HW, Rino JG, Wexler RB, et al.: Mycoplasma pneumoniae infection increases airway collagen deposition in a murine model of allergic airway inflammation. Am J Physiol Lung Cell Mol Physiol 2005, 289:L125–L133.
Gonzales R, Steiner JF, Sande MA: Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. JAMA 1997, 278:901–904.
McCaig LF, Hughes JM: Trends in antimicrobial drug prescribing among office-based physicians in the United States. JAMA 1995, 273:214–219.
Hirschmann JV: Antibiotics for common respiratory tract infections in adults. Arch Intern Med 2002, 162:256–264.
Graham VA, Milton AF, Knowles GK, et al.: Routine antibiotics in hospital management of acute asthma. Lancet 1982, 1:418–420.
Shapiro GG, Eggleston PA, Pierson WE, et al.: Double-blind study of the effectiveness of a broad spectrum antibiotic in status asthmaticus. Pediatrics 1974, 53:867–872.
Johnston SL, Blasi F, Black PN, et al.: The effect of telithromycin in acute exacerbations of asthma. N Engl J Med 2006, 354:1589–1600.
•• Krishnan JA, Nowak R, Davis SQ, et al.: Anti-inflammatory treatment after discharge home from the emergency department in adults with acute asthma. Proc Am Thorac Soc 2009, 6:380–385. This is a review of 37 controlled trials of outpatient treatment of acute asthma exacerbations comparing different treatment programs. It includes a review of the study by Johnston et al. [30].
Michels N, Chu HW, LaFasto S, et al.: Mast cells mediate Mycoplasma pneumoniae clearance after acute infection. Am J Respir Crit Care Med 2009 (in press).
Itkin IH, Menzel ML: The use of macrolide antibiotic substances in the treatment of asthma. J Allergy 1970, 45:146–162.
Jaffe A, Bush A: Anti-inflammatory effects of macrolides in lung disease. Pediatr Pulmonol 2001, 31:464–473.
Garey KW, Rubinstein I, Gotfried MH, et al.: Long-term clarithromycin decreases prednisone requirements in elderly patients with prednisone-dependent asthma. Chest 2000, 118:1826–1827.
Yalcin E, Kiper N, Ozcelik U, et al.: Effects of claritromycin on inflammatory parameters and clinical conditions in children with bronchiectasis. J Clin Pharm Ther 2006, 31:49–55.
Tahan F, Ozcan A, Koc N: Clarithromycin in the treatment of RSV bronchiolitis: a double-blind, randomised, placebo-controlled trial. Eur Respir J 2007, 29:91–97.
Yamada T, Fujieda S, Mori S, et al.: Macrolide treatment decreased the size of nasal polyps and IL-8 levels in nasal lavage. Am J Rhinol 2000, 14:143–148.
Simpson JL, Powell H, Boyle MJ, et al.: Clarithromycin targets neutrophilic airway inflammation in refractory asthma. Am J Respir Crit Care Med 2008, 177:148–155.
Gibson PG, Simpson JL, Saltos N: Heterogeneity of airway inflammation in persistent asthma: evidence of neutrophilic inflammation and increased sputum interleukin-8. Chest 2001, 119:1329–1336.
Labro MT, Abdelghaffar H: Immunomodulation by macrolide antibiotics. J Chemother 2001, 13:3–8.
Kawasaki S, Takizawa H, Ohtoshi T, et al.: Roxithromycin inhibits cytokine production by and neutrophil attachment to human bronchial epithelial cells in vitro. Antimicrob Agents Chemother 1998, 42:1499–1502.
Takizawa H, Desaki M, Ohtoshi T, et al.: Erythromycin suppresses interleukin 6 expression by human bronchial epithelial cells: a potential mechanism of its anti-inflammatory action. Biochem Biophys Res Commun 1995, 210:781–786.
Fost DA, Leung DY, Martin RJ, et al.: Inhibition of methylprednisolone elimination in the presence of clarithromycin therapy. J Allergy Clin Immunol 1999, 103:1031–1035.
Black PN: Anti-inflammatory effects of macrolide antibiotics. Eur Respir J 1997, 10:971–972.
Periti P, Mazzei T, Mini E, et al.: Pharmacokinetic drug interactions of macrolides. Clin Pharmacokinet 1992, 23:106–131.
Siracusa A, Brugnami G, Fiordi T, et al.: Troleandomycin in the treatment of difficult asthma. J Allergy Clin Immunol 1993, 92:677–682.
Garey KW, Alwani A, Danziger LH, et al.: Tissue reparative effects of macrolide antibiotics in chronic inflammatory sinopulmonary diseases. Chest 2003, 123:261–265.
Kroegel C, Rodel J, Mock B: Chlamydia pneumoniae, clarithromycin, and severe asthma. Chest 2001, 120:1035–1036.
Kamada AK, Hill MR, Ikle DN, et al.: Efficacy and safety of low-dose troleandomycin therapy in children with severe, steroid-requiring asthma. J Allergy Clin Immunol 1993, 91:873–882.
Nelson HS, Hamilos DL, Corsello PR, et al.: A double-blind study of troleandomycin and methylprednisolone in asthmatic subjects who require daily corticosteroids. Am Rev Respir Dis 1993, 147:398–404.
Ekici A, Ekici M, Erdemoglu AK: Effect of azithromycin on the severity of bronchial hyperresponsiveness in patients with mild asthma. J Asthma 2002, 39:181–185.
Shimizu T, Kato M, Mochizuki H, et al.: Roxithromycin reduces the degree of bronchial hyperresponsiveness in children with asthma. Chest 1994, 106:458–461.
Kamoi H, Kurihara N, Fujiwara H, et al.: The macrolide antibacterial roxithromycin reduces bronchial hyperresponsiveness and superoxide anion production by polymorphonuclear leukocytes in patients with asthma. J Asthma 1995, 32:191–197.
Amayasu H, Yoshida S, Ebana S, et al.: Clarithromycin suppresses bronchial hyperresponsiveness associated with eosinophilic inflammation in patients with asthma. Ann Allergy Asthma Immunol 2000, 84:594–598.
Disclosure
No potential conflicts of interest relevant to this article were reported.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rollins, D.R., Beuther, D.A. & Martin, R.J. Update on Infection and Antibiotics in Asthma. Curr Allergy Asthma Rep 10, 67–73 (2010). https://doi.org/10.1007/s11882-009-0086-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11882-009-0086-2